These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 2136214)

  • 1. C-EEG brain mapping in DSM-III schizophrenics after acute and chronic haloperidol treatment.
    Galderisi S; Mucci A; Di Gregorio MR; Bucci P; Maj M; Kemali D
    Eur Neuropsychopharmacol; 1990 Nov; 1(1):51-4. PubMed ID: 2136214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Computerized EEG topography findings in schizophrenic patients before and after haloperidol treatment.
    Kemali D; Galderisi S; Maj M; Mucci A; Di Gregorio M; Bucci P
    Int J Psychophysiol; 1992 Dec; 13(3):283-90. PubMed ID: 1459885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EEG-brain mapping in schizophrenics with predominantly positive and negative symptoms. Comparative studies with remoxipride/haloperidol.
    Saletu B; Küfferle B; Anderer P; Grünberger J; Steinberger K
    Eur Neuropsychopharmacol; 1990 Nov; 1(1):27-36. PubMed ID: 1983779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CEEG mapping in drug-free schizophrenics. Differences from healthy subjects and changes induced by haloperidol treatment.
    Galderisi S; Mucci A; Mignone ML; Maj M; Kemali D
    Schizophr Res; 1991 Dec; 6(1):15-23. PubMed ID: 1786232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EEG- and EP-mapping--possible indicators for disturbed information processing in schizophrenia?
    Schellenberg R; Schwarz A
    Prog Neuropsychopharmacol Biol Psychiatry; 1993 Jul; 17(4):595-607. PubMed ID: 8103234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pretreatment EEG predicts short-term response to haloperidol treatment.
    Czobor P; Volavka J
    Biol Psychiatry; 1991 Nov; 30(9):927-42. PubMed ID: 1747438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EEG power variation in schizophrenic subgroups: effects of emotionally salient stimuli.
    Kessler C; Kling A
    Biol Psychiatry; 1991 Aug; 30(4):335-48. PubMed ID: 1912124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Slower theta activity over the midfrontal cortex in schizophrenic patients.
    Westphal KP; Grözinger B; Diekmann V; Scherb W; Reess J; Leibing U; Kornhuber HH
    Acta Psychiatr Scand; 1990 Feb; 81(2):132-8. PubMed ID: 2327275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Computerized EEG profiles of haloperidol, chlorpromazine, clozapine and placebo in treatment resistant schizophrenia.
    Small JG; Milstein V; Small IF; Miller MJ; Kellams JJ; Corsaro CJ
    Clin Electroencephalogr; 1987 Jul; 18(3):124-35. PubMed ID: 3652464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Level of haloperidol in plasma is related to electroencephalographic findings in patients who improve.
    Czobor P; Volavka J
    Psychiatry Res; 1992 May; 42(2):129-44. PubMed ID: 1631250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical, EEG mapping and psychometric studies in negative schizophrenia: comparative trials with amisulpride and fluphenazine.
    Saletu B; Küfferle B; Grünberger J; Földes P; Topitz A; Anderer P
    Neuropsychobiology; 1994; 29(3):125-35. PubMed ID: 7912819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abnormal EEG patterns in treatment-resistant schizophrenic patients.
    Ramos J; Cerdán LF; Guevara MA; Amezcua C; Sanz A
    Int J Neurosci; 2001 Jul; 109(1-2):47-59. PubMed ID: 11699340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Predicting the effects of haloperidol on schizophrenics by quantitative pharmaco-EEG].
    Zhang XL
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1992 Oct; 25(5):300-2, 318. PubMed ID: 1291253
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrated EEG. variability: drug effects in acute schizophrenics.
    Marjerrison G; Keogh RP
    Can Psychiatr Assoc J; 1969 Aug; 14(4):403-5. PubMed ID: 4897659
    [No Abstract]   [Full Text] [Related]  

  • 15. Quantitative EEG in schizophrenic patients before and during pharmacotherapy.
    Begić D; Hotujac L; Jokić-Begić N
    Neuropsychobiology; 2000; 41(3):166-70. PubMed ID: 10754432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypofrontality on topographic EEG in schizophrenia. Correlations with neuropsychological and psychopathological parameters.
    Gattaz WF; Mayer S; Ziegler P; Platz M; Gasser T
    Eur Arch Psychiatry Clin Neurosci; 1992; 241(6):328-32. PubMed ID: 1504108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Somatosensory-evoked potential changes during haloperidol treatment of chronic schizophrenics.
    Saletu B; Saletu M; Itil T; Marasa J
    Biol Psychiatry; 1971; 3(4):299-307. PubMed ID: 5163816
    [No Abstract]   [Full Text] [Related]  

  • 18. Quantitative electroencephalogram examination of effects of risperidone in schizophrenic patients.
    Czobor P; Volavka J
    J Clin Psychopharmacol; 1993 Oct; 13(5):332-42. PubMed ID: 7693770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Quantitative analysis of EEG background activity in drug-naive schizophrenic patients].
    Takizawa Y; Wada Y; Horita M; Kitazawa S; Futamata H; Hashimoto T
    Rinsho Byori; 1994 Jul; 42(7):759-63. PubMed ID: 8065045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative EEG in schizophrenia and in response to acute and chronic clozapine treatment.
    Knott V; Labelle A; Jones B; Mahoney C
    Schizophr Res; 2001 May; 50(1-2):41-53. PubMed ID: 11378313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.